ACTRN12614001207606: Phase I Dose-Escalation Extension Study to Determine the Safety and Tolerability of Intratumoural Injection(s) of EBC-46 |
|
|
| Completed | 1 | 15 | | | QBiotics Limited, QBiotics Limited | Cutaneous, subcutaneous, head and neck*, or nodal tumours
*except for pharyngeal, laryngeal and tongue base tumours and those tumours in the anterior neck (from posterior border of sternocleidomastoid on each side) | | | | |
ACTRN12614000685617: Phase I Dose-Escalation Study to Determine the Safety and Tolerability of an Intratumoural Injection of EBC-46 |
|
|
| Completed | 1 | 15 | | | QBiotics Limited, QBiotics Limited | Cutaneous, subcutaneous, head and neck*, or nodal tumours
*except for pharyngeal, laryngeal and tongue base tumours and those tumours in the anterior neck (from posterior border of sternocleidomastoid on each side) | | | | |
